{
    "code": "02022134",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022134",
    "time": "2020-02-25 12:51:05",
    "許可證字號": "衛署藥輸字第022134號",
    "註銷狀態": "已註銷",
    "註銷日期": "94\/06\/03",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "91\/10\/29",
    "發證日期": "87\/04\/22",
    "許可證種類": "製　劑",
    "舊證字號": "02019571",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202213400",
    "中文品名": "美腺龍凍晶注射劑",
    "英文品名": "METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION &quot;DBL&quot;",
    "適應症": "急性病症（氣喘、休克、過敏性疾患）。",
    "劑型": "243凍晶注射劑",
    "包裝": "盒裝 小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "METHYLPREDNISOLONE (SODIUM SUCCINATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "1316201100  瑞帝有限公司",
    "申請商地址": "台北巿建國北路二段８５號２樓",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0031100  F.H. FAULDING CO., LTD. (TRADING AS DAVID BULL LABORATORIES)",
            "製造廠廠址": "1-23 LEXIA PLACE, MULGRAVE VICTORIA 3170 AUSTRALIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804091331",
            "成分名稱": "METHYLPREDNISOLONE (SODIUM SUCCINATE)",
            "含量描述": "500",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ]
}